Mei W. Chen,Cindy Collins,Matthew L. Eaton,Matthew G. Guenther,Nan Ke,Jeremy Lopez,Michael R. McKeown,David A. Orlando
申请号：
US15899629
公开号：
US20180187271A1
申请日:
2018.02.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention provides methods that define cellular populations that are sensitive to RARA agonists and identify patient subgroups that will benefit from treatment with RARA agonists. The invention also provides packaged pharmaceutical compositions that comprise a RARA agonist and instructions for determining if such agonist is suitable for use in treatment.
